The biopreservation media providers market is projected to grow at an annualized rate of 23.57%.


The projected market opportunity is likely to be well distributed across different end users, biological samples, packaging formats and key geographical regions.

.

Roots Analysis has done a detailed study on “Biopreservation Media Providers Market, 2021-2035”, covering key aspects of the market’s evolution and identifying potential future growth opportunities.

 

To order this 230+ page report, which features 90+ figures and 100+ tables, please visit this link

 

Key Market Insights

  • Presently, over 60 players claim to be engaged in providing biopreservation media.
  • Over 190 biopreservation media are presently offered across the globe, intended for the preservation of biological samples at different preservation conditions.
  • In order to build a competitive advantage, companies are focused on steadily improving the characteristics of their media offerings.
  • The growing interest is also evident from the rise in partnership activity, a relatively larger proportion of the deals were signed by companies based in the US.
  • Driven by the rising approval of temperature sensitive products, the market for biopreservation media providers is poised to grow at an annualized rate of 23.57%, till 2035.
  • The projected market opportunity is likely to be well distributed across different end users, biological samples, packaging formats and key geographical regions.

 

For additional details, please visit

https://www.rootsanalysis.com/reports/biopreservation-media-providers-market.html

 

Table of Contents

  1. PREFACE

1.1.       Scope of the Report

1.2.       Research Methodology

1.3.       Key Questions Answered

1.4.       Chapter Outlines

 

  1. EXECUTIVE SUMMARY

2.1.      Chapter Overview

           

  1. INTRODUCTION

3.1.      Chapter Overview

3.2.       Introduction to Biopreservation

3.3.       Type of Biopreservation

3.3.1.    Hypothermic Preservation

3.3.2.    Cryopreservation

 

3.4.       Applications of Biopreservation Media

3.5.       Benefits and Limitations of Biopreservation Media

3.6.      Concluding Remarks

 

  1. MARKET LANDSCAPE

4.1.      Chapter Overview

4.2.       Biopreservation Media Providers: Service Providers Landscape

4.2.1.    Analysis by Year of Establishment

4.2.2.    Analysis by Company Size

4.2.3.    Analysis by Type of Company

4.2.4.    Analysis by Location of Headquarters

 

4.3.      Biopreservation Media: Market Landscape

4.3.1.    Analysis by Preservation Condition

4.3.2.    Analysis by Type of Serum

4.3.3.    Analysis by Type of Biological Sample

4.3.4.    Analysis by Area of Application

4.3.5.    Analysis by Type of Packaging Format

4.3.6.    Analysis by Packaging Volume

4.3.7.    Analysis by Product Price

 

  1. KEY INSIGHTS

5.1.       Chapter Overview

5.2.      Analysis by Location of Headquarters (World Map Representation)

5.3.      Analysis by Year of Establishment, Company Size, Number of Biopreservation Media Offered and Region (4D Bubble Chart)

5.4.      Analysis by Preservation Condition and Area of Application (Treemap Representation)

5.5.      Analysis by Company Size, Region, Preservation Condition, Type of Serum and Type of Biological Sample (Grid Representation)

5.6.      Analysis by Minimum Packaging Volume and Minimum Price (Heat Map Representation)

 

  1. COMPANY COMPETITIVENESS

6.1.      Chapter Overview

6.2.      Assumptions and Key Parameters

6.3.       Methodology

6.4.       Benchmarking of Product Portfolio Strength

6.5.      Benchmarking of Partnership Activity

6.6.      Biopreservation Media Providers: Company Competitiveness Analysis

6.6.1.    Company Competitiveness Analysis: Very Small Companies

6.6.2.    Company Competitiveness Analysis: Small Companies

6.6.3.    Company Competitiveness Analysis: Mid-Sized Companies

6.6.4.    Company Competitiveness Analysis: Large Companies

 

  1. COMPANY PROFILES

7.1.      Chapter Overview

7.2.      BioLife Solutions

7.2.1.    Company Overview

7.2.2.    Recent Developments and Future Outlook

 

7.3.      Cell Applications

7.3.1.    Company Overview

7.3.2.    Recent Developments and Future Outlook

 

7.4.       HiMedia Laboratories

7.4.1.    Company Overview

7.4.2.    Recent Developments and Future Outlook

 

7.5.       Merck

7.5.1.    Company Overview

7.5.2.    Recent Developments and Future Outlook

 

7.6.       Thermo Fischer Scientific

7.6.1.    Company Overview

7.6.2.    Recent Developments and Future Outlook

 

7.7.       United States Biological

7.7.1.    Company Overview

7.7.2.    Recent Developments and Future Outlook

 

7.8.       ZenBio

7.8.1.    Company Overview

7.8.2.    Recent Developments and Future Outlook

 

 

  1. PARTNERSHIPS AND COLLABORATIONS

8.1.       Chapter Overview

8.2.       Partnership Models

8.3.      Biopreservation Media Providers: Partnerships and Collaborations

8.3.1.    Analysis by Year of Partnership

8.3.2.    Analysis by Type of Partnership

8.3.2.1. Analysis by Year and Type of Partnership

8.3.2.2. Analysis by Type of Partnership and Company Size

 

8.3.3.    Analysis by Type of Partner

8.3.3.1. Analysis by Year of Partnership and Type of Partner

8.3.3.2. Analysis by Type of Partner and Type of Partnership

8.3.3.3. Analysis by Type of Partner and Company Size

 

8.3.4.    Most Active Players: Analysis by Number of Partnerships

8.3.5.    Regional Analysis

8.3.5.1. Local and International Deals

8.3.5.2. Intercontinental and Intracontinental Deals

8.3.5.3. Analysis by Location of Headquarters of Partner

8.3.5.4. Analysis by Location of Headquarters of Partner and Type of Partnership

 

  1. BOWMAN CLOCK PRICING STRATEGY

9.1.       Chapter Overview

9.2.      Bowman Strategy Clock

9.2.1.    Two Dimensions of Bowman Strategy Clock

9.2.2.    Eight Positions on Bowman Strategy Clock

 

9.3.      Roots Analysis Framework

9.3.1.    Methodology

9.3.2.    Theoretical Framework and Price Evaluation Hypothesis

9.3.3.    Results and Interpretation

9.3.3.1. Bowman Clock Pricing Strategy Graphical Representation

9.3.3.2. Product Price Evaluation Matrix: Information on Preservation Condition

9.3.3.3. Product Price Evaluation Matrix: Information on Type of Serum

9.3.3.4. Product Price Evaluation Matrix: Information on Type of Biological Sample

9.3.3.5. Product Price Evaluation Matrix: Information on Minimum Packaging Volume

9.3.3.6. Product Price Evaluation Matrix: Information on Maximum Packaging Volume

9.3.3.7. Product Price Evaluation Matrix: Information on Packaging Format

9.3.3.8. Product Price Evaluation Matrix: Information on Area of Application

 

  1. MARKET SIZING AND OPPORTUNITY ANALYSIS

10.1.     Chapter Overview

10.2.     Forecast Methodology and Key Assumptions

10.3.     Biopreservation Media Providers Market, 2021-2035

10.4.     Biopreservation Media Providers Market: Distribution by Preservation                                     Condition, 2021 and 2035

10.4.1.  Biopreservation Media Providers Market for Cryogenic / LN2 Vapor Phase, 2021-2035

10.4.2.  Biopreservation Media Providers Market for Frozen (Ultra-low) / Deep Frozen, 2021-2035

10.4.3.  Biopreservation Media Providers Market for Frozen / Cold Chain, 2021-2035

10.4.4.  Biopreservation Media Providers Market for Refrigerated, 2021-2035

 

10.5.     Biopreservation Media Providers Market: Distribution by Type of Serum, 2021 and 2035

10.5.1.  Biopreservation Media Providers Market for Fetal Bovine Serum Containing Media, 2021-2035

10.5.2.  Biopreservation Media Providers Market for Fetal Calf Serum Containing        Media, 2021-2035

10.5.3.  Biopreservation Media Providers Market for Human Serum Containing Media, 2021-2035

10.5.4.  Biopreservation Media Providers Market for Serum Free Media, 2021-2035

 

10.6.     Biopreservation Media Providers Market: Distribution by Type of Biological Sample, 2021 and 2035

10.6.1.  Biopreservation Media Providers Market for Germline Cells / Stem Cells, 2021-2035

10.6.2.  Biopreservation Media Providers Market for Organs, 2021-2035

10.6.3.  Biopreservation Media Providers Market for Somatic Cells, 2021-2035

10.6.4.  Biopreservation Media Providers Market for Tissues, 2021-2035

 

10.7.     Biopreservation Media Providers Market: Distribution by Area of Application, 2021 and 2035

10.7.1.  Biopreservation Media Providers Market for Diagnostic Use, 2021-2035

10.7.2.  Biopreservation Media Providers Market for Research and Development, 2021-2035

10.7.3.  Biopreservation Media Providers Market for Therapeutic Use, 2021-2035

 

10.8.     Biopreservation Media Providers Market: Distribution by Type of Packaging Format, 2021 and 2035

10.8.1.  Biopreservation Media Providers Market for Bags, 2021-2035

10.8.2.  Biopreservation Media Providers Market for Bottles, 2021-2035

10.8.3.  Biopreservation Media Providers Market for Vials, 2021-2035

10.8.4.  Biopreservation Media Providers Market for Others, 2021-2035

 

10.9.     Biopreservation Media Providers Market: Distribution by End Users, 2021 and 2035

10.9.1.  Biopreservation Media Providers Market for Academic and Research Institutes, 2021-2035

10.9.2.  Biopreservation Media Providers Market for Biobanks / Genebanks, 2021-2035

10.9.3.  Biopreservation Media Providers Market for Hospitals, 2021-2035

10.9.4.  Biopreservation Media Providers Market for Pharmaceutical and Biotechnology Companies, 2021-2035

10.9.5.  Biopreservation Media Providers Market for Other End Users, 2021-2035

 

10.10.   Biopreservation Media Providers Market: Distribution by Region, 2021 and 2035

10.10.1. Biopreservation Media Providers Market in North America, 2021-2035

10.10.2. Biopreservation Media Providers Market in Europe, 2021-2035

10.10.3. Biopreservation Media Providers Market in Asia, 2021-2035

10.10.4. Biopreservation Media Providers Market in MENA, 2021-2035

10.10.5. Biopreservation Media Providers Market in Latin America, 2021-2035

10.10.6. Biopreservation Media Providers Market in Rest of the World, 2021-2035

 

10.11.   Concluding Remarks

 

  1. CONCLUSION

11.1.     Chapter Overview

 

  1. EXECUTIVE INSIGHTS

12.1.     Chapter Overview

12.2.     Cytes Biotechnologies

12.2.1.  Company Snapshot

12.2.2.  Interview Transcript: Robert Gobern, Marketing Director

 

  1. APPENDIX I: TABULATED DATA

 

  1. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

 

Contact Details

Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]